Revenue FY2025
$0.0M
Net Income
$(90.0M)
EPS (Basic)
$-4.24
Net Margin
—
ROE
-34.1%
Total Equity
$265.0M
Shares Out
20M
Neurogene Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2012–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Baker Bros. Advisors
Baker Bros. Advisors
$31.2M
0.1%
—
Alps Advisors
Alps Advisors
$0.5M
0.0%
+27.2%
Insider Transactions
Reading stored insider transactions…